Inhaled Ampion News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Inhaled ampion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Inhaled Ampion Today - Breaking & Trending Today
Analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a research report issued on Sunday. The brokerage set a “sell” rating on the stock. Shares of NYSE AMPE opened at $0.16 on Friday. The stock has a market capitalization of $36.80 million, a PE ratio of -1.47 and a […] ....
Brokerages expect Ampio Pharmaceuticals, Inc. (NYSE:AMPE – Get Rating) to announce earnings per share (EPS) of ($0.02) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Ampio Pharmaceuticals’ earnings. Ampio Pharmaceuticals also posted earnings of ($0.02) per share in the same quarter last year. The firm is expected to […] ....
Equities research analysts expect that Ampio Pharmaceuticals, Inc. (NYSE:AMPE – Get Rating) will announce earnings of ($0.02) per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Ampio Pharmaceuticals’ earnings. Ampio Pharmaceuticals also posted earnings per share of ($0.02) during the same quarter last year. The business is […] ....
StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a report released on Sunday. The firm set a “sell” rating on the stock. Shares of Ampio Pharmaceuticals stock opened at $0.28 on Friday. The business’s fifty day simple moving average is $0.44. Ampio Pharmaceuticals has a 1 year low of $0.21 […] ....
Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) had its price target reduced by equities research analysts at Alliance Global Partners from $4.50 to $3.00 in a report issued on Friday, The Fly reports. Separately, Zacks Investment Research lowered shares of Ampio Pharmaceuticals from a “hold” rating to a “strong sell” rating in a report on Friday, […] ....